SCREENING FEE Sample Clauses

SCREENING FEE. Mitsubishi will pay NeoGenesis a screening fee of [*] for the NeoGenesis services pursuant to the Program. Mitsubishi will pay this fee within thirty (30) days of the Effective Date. *= CONFIDENTIAL TREATMENT REQUESTED: MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.
AutoNDA by SimpleDocs
SCREENING FEE. Daiichi shall pay to Anadys a nonrefundable-screening fee of [...***...] United States Dollars (US $[...***...]) within twenty-one (21) days after the Effective Date.
SCREENING FEE. Tularik shall pay NeoGenesis a fee of [*] for each Screening Target screened pursuant to the Screening Program. Such fee shall be payable in two (2) installments - the first installment of [*] at the time such Screening Target is delivered to NeoGenesis and the second installment of [*] within [*]of Completion of Screening; provided, however, that the amount of the second installment shall be reduced for a particular Screening Target by [*] if Completion of Screening does not occur within [*] following delivery of such Screening Target to NeoGenesis. COMPLETION OF SCREENING shall be deemed to occur upon delivery of Selected Screening Compounds for a Screening Target to Tularik (or, if Tularik does not designate any Selected Screening Compound(s) for such Screening Target within [*] of receipt of the Final Target Report for such Screening Target, including any supplement thereto as described in Paragraph 7 of ATTACHMENT A, then at the end of such [*] period). No payment shall be due NeoGenesis under this Section 4.2 with respect to Shared Targets.
SCREENING FEE. With each Screening Request made by Taisho under Section 6.1 of this Agreement, Taisho shall simultaneously provide to Arena a Screening Fee of [******************************************]. Upon receipt of such Screening Fee, the following shall apply: (a) For each Taisho Activated Receptor and its corresponding Screening Assay, Arena, using Best Reasonable Commercial Efforts, shall utilize the Taisho Activated Receptor and the Screening Assay for Screening using Arena Library Compounds ("Arena Screening"). (b) For each Taisho Activated Receptor subject to Arena Screening, Arena shall use Best Reasonable Commercial Efforts to identify at least [*******] CART Identified Compound.
SCREENING FEE. With EACH Screening Request made by Taisho under Section 6.1 of this Agreement, Taisho shall simultaneously provide to Arena a Screening Fee of [*************************** (*******)]. Upon receipt of such Screening Fee, the following shall apply: (a) For EACH Taisho Activated Receptor and its corresponding Screening Assay, Arena, using Best Reasonable Commercial Efforts, shall utilize the Taisho Activated Receptor and the Screening Assay for Screening using Arena Library Compounds ("Arena Screening"). (b) For EACH Taisho Activated Receptor subject to Arena Screening, Arena shall use Best Reasonable Commercial Efforts to identify at least [*** (**)] CART Identified Compound. (c) The Parties acknowledge and understand that once made, EACH Screening Fee shall be non-refundable and non-creditable, and that the maximum amount that Taisho would be required to pay to Arena under this Section 6.2 is [************************ (*******)] in the event that Taisho provides [**** (**)] Screening Requests to Arena.
SCREENING FEE. Aventis shall pay NeoGenesis a fee of [*] for each Screening Target screened pursuant to the Program that is a non-protein/protein interaction Screening Target and a fee of [*] for each Screening Target screened pursuant to the Program that is a protein/protein interaction Screening Target. Such fee shall be payable with respect to the first [*] Screening Targets in two installments: the first installment of [*] on the Effective Date and the second installment consisting of the remaining balance due in accordance with the immediately preceding sentence within [*] of "completion of screening" against all [*] of the Screening Targets. "Completion of screening" for each Screening Target shall be deemed to occur upon delivery of Hit Compounds for such Screening Target to Aventis (or, if Aventis does not designate any Hit Compound(s) for such Screening Target, within [*] of receipt of the Final Target Report for such Screening Target, then at the end of such [*] period). Any work conducted for further optimization and evaluation of Hit Compounds to Selected Series or to Lead Compounds will be carried out on FTE basis in accordance with Section 4.2 and Paragraphs 7-8 of ATTACHMENT A.
SCREENING FEE. CUSTOMER will pay NeoGenesis a screening fee of [*] per accepted Target for the NeoGenesis services pursuant to the Program with respect to such Target. CUSTOMER will pay this fee within [*] of the effective date of a designated Target being accepted by NeoGenesis. In addition, CUSTOMER will pay NeoGenesis a fee of [*] per Target in FTE funding for the Program ([*] people for [*] at an FTE of [*]). Such FTE funding shall be paid at the commencement of each Program. Any additional FTE funding for a Target (for Program services beyond those specified in paragraphs 1-7 and 9 of ATTACHMENT A (i.e., optimization of three Selected Compounds to a Kd value of [*] and [*] of optimization on [*] Selected Compounds) must be approved by the Steering Committee on a Target-by-Target basis and will be charged at the rate of [*] per FTE. In addition to the fees described above, at the completion of each Program CUSTOMER shall pay to NeoGenesis a fee of [*].
AutoNDA by SimpleDocs

Related to SCREENING FEE

  • Cleaning Fee Tenant hereby agrees to accept property in its present state of cleanliness. They agree to return the property in the same condition or pay a $200.00 minimum cleaning fee if the Landlord has to have the property professionally cleaned.

  • Monitoring Fee The Owners agree to pay the Council’s costs and expenses incurred or to be to be incurred by the Council in the administration and monitoring of the provisions of his Agreement in the sum of £400.00 such sum to be paid to the Council on the Effective Date

  • Development Fee A fee for the packaging of a Property or Mortgage, including the negotiation and approval of plans, and any assistance in obtaining zoning and necessary variances and financing for a specific Property, either initially or at a later date.

  • Incentive Fee In the event that the actual costs for the development and construction of the Project are less than the Projected Project Costs (such difference being referred to as the "Savings"), fifty percent (50%) of the Savings shall be paid to the Developer as an incentive fee.

  • Utilization Fee If the aggregate outstanding amount of (i) all Revolving Credit Advances hereunder and (ii) all "Revolving Credit Advances" under (and as defined in) the Three-Year Agreement exceeds thirty-three percent (33%) of the aggregate amount of (x) all Commitments hereunder and (y) all "Commitments" under (and as defined in) the Three-Year Agreement then in effect on such date (or, if any of the Commitments or "Commitments" have been terminated, the aggregate amount of all Commitments and "Commitments" in effect immediately prior to such termination), the Borrower will pay to the Agent for the ratable benefit of the Lenders a utilization fee (the "Utilization Fee") at a per annum rate equal to the Applicable Utilization Fee Rate in effect from time to time payable on the aggregate outstanding amount of all Revolving Credit Advances on such date, payable in arrears quarterly on the last day of each March, June, September and December, and on the Revolver Termination Date.

  • Ticking Fee The Borrower shall pay to the Administrative Agent for the account of each Term B Lender in accordance with its Applicable Term B Percentage, a ticking fee (the “Ticking Fee”) (i) for the period commencing on the Closing Date and ending on (but not including) March 3, 2013, equal to 1.75% per annum on the actual daily amount by which the aggregate Term B Commitment (as it may be reduced by a Permitted Term B Reallocation) exceeds the sum of the aggregate Outstanding Amount of Term B Loans, subject to adjustment as provided in Section 2.16, and (ii) for the period commencing on March 3, 2013 and ending on the Term B Advance Period Termination Date, equal to 3.50% per annum on the actual daily amount by which the aggregate Term B Commitment (as it may be reduced by a Permitted Term B Reallocation) exceeds the sum of the aggregate Outstanding Amount of Term B Loans, subject to adjustment as provided in Section 2.16. The Ticking Fee shall accrue at all times during the Term B Advance Period, including at any time during which one or more of the conditions in Article IV is not met, and shall be due and payable quarterly in arrears on the last Business Day of each March, June, September and December, commencing with the first such date to occur after the Closing Date, and on the Term B Advance Period Termination Date. The Ticking Fee shall be calculated quarterly in arrears.

  • Upfront Fee The Borrower shall pay to the Agent (for the account of each Original Lender) an upfront fee in the amount and at the times agreed in a Fee Letter.

  • Up-Front Fee The Borrowers shall pay to the Agent an up-front fee in the amount and at the times agreed in a Fee Letter.

  • Closing Fee On the Effective Date, the Borrower agrees to pay to the Administrative Agent and each Lender all loan fees as have been agreed to in writing by the Borrower and the Administrative Agent.

  • Processing Fee At the time each Advance is made, Borrower shall pay to Lender the Processing Fee with respect to such Advance.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!